-10.4%
RKT vs GSK
+14.9%
-25.4%
-55.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.7% | +5.0% | +3.7% | +6.5% |
| 7D | +29.7% | +4.9% | +24.8% | +27.1% |
| 30D | +28.5% | +9.9% | +18.6% | +24.0% |
| 3M | +6.4% | +0.2% | +6.2% | +6.2% |
| 6M | +7.1% | +2.3% | +4.8% | +5.4% |
| YTD | -22.5% | +7.1% | -29.5% | -22.4% |
| 1Y | -10.4% | +13.1% | -23.6% | -13.9% |
| All | -10.4% | +14.9% | -25.4% | -13.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling